3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
1
Interventions
Specimen Handling
317
Magnetic Resonance Spectroscopy
275
pembrolizumab
268
Carboplatin
190
Cyclophosphamide
182
Biopsy
175
Cisplatin
164
Gemcitabine
139
Paclitaxel
137
Bevacizumab
122
fludarabine
119
Nivolumab
115
Radiotherapy
114
Oxaliplatin
96
venetoclax
94
Fluorouracil
90
Docetaxel
87
Dexamethasone
86
Capecitabine
86
Drug Therapy
76
Rituximab
74
Pemetrexed
72
Leucovorin
71
durvalumab
70
Radiosurgery
69
Blood Specimen Collection
69
Standard of Care
68
Doxorubicin
64
atezolizumab
62
Radiation
62
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Clomiphene
×
90 days
×
Clear all
NCT03059173
2026-04-22
MYOPK
University Hospital, Lille
Phase 3
Recruiting
276 enrolled